Jing You
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.
Journal: Science translational medicine
Published: February 04, 2026
Discovery and Structure-Activity Relationship Studies of Diazepine Derivatives as a New Class of Ferroptosis Inhibitors with Potent Efficacy in the Doxorubicin-Induced Cardiomyopathy Model.
Journal: Journal of medicinal chemistry
Published: January 30, 2026
Discovery of phenazine derivatives as a new class of non-classical ferroptosis inhibitors and efficacy evaluation on a mouse model of liver injury.
Journal: European journal of medicinal chemistry
Published: August 31, 2024
Discovery of 5-((1H-indazol-3-yl) methylene)-2-thioxoimidazolidin-4-one derivatives as a new class of AHR agonists with anti-psoriasis activity in a mouse model.
Journal: Bioorganic & medicinal chemistry letters
Published: May 21, 2023
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants.
Journal: Signal transduction and targeted therapy
Published: February 04, 2023
Discovery of 3-phenyl-1,2,4-oxadiazole derivatives as a new class of SARS-CoV-2 main protease inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: December 19, 2022
The Operation Mode of Agricultural Supply Chain Finance Using Blockchain.
Journal: Computational intelligence and neuroscience
Published: July 11, 2022
Non-classical ferroptosis inhibition by a small molecule targeting PHB2.
Journal: Nature communications
Published: May 24, 2022
Discovery of 2-vinyl-10H-phenothiazine derivatives as a class of ferroptosis inhibitors with minimal human Ether-a-go-go related gene (hERG) activity for the treatment of DOX-induced cardiomyopathy.
Journal: Bioorganic & medicinal chemistry letters
Published: April 13, 2022
Structure-Guided Discovery of a Potent and Selective Cell-Active Inhibitor of SETDB1 Tudor Domain.
Journal: Angewandte Chemie (International ed. in English)
Published: December 27, 2020
SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model.
Journal: Science (New York, N.Y.)
Published: October 09, 2020
Last Updated: 09/26/2026